Industry | 2012.12.19
Teva Signs New $3.0 Billion Syndicated Revolving Credit Facility
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it has entered into a new five-year, $3.0 billion unsecured revolving credit facility, which replaces its existing $2.5 billion credit facility. “By signing this new revolving credit facility, with its increased size and extended term, we took another step on our recently announced new strategy and secured ample liquidity to support Teva\'s future growth," stated Eyal Desheh, Executive Vice President
For more information, please visit
http://www.businesswire.com/news/home/20[...]on-Syndicated-Revolving-Credit
